Position in MNOV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,369
-$29,702 QoQ
Shares Held
13,159
-61.7% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 29 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNOV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. MNOV ranks #331 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in MNOV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,369 | 13,159 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $47,071 | 34,359 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $39,303 | 30,003 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $116,155 | 91,462 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $123,731 | 94,452 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $189,770 | 129,980 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $338,754 | 161,312 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $160,331 | 76,349 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $170,870 | 118,661 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $215,265 | 148,459 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $251,938 | 167,959 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $181,117 | 86,659 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $249,455 | 108,459 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $290,215 | 134,359 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $363,380 | 177,259 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $335,809 | 154,751 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $403,410 | 159,451 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $479,202 | 179,477 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $566,974 | 211,558 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $547,442 | 144,444 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $717,242 | 168,763 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $386,132 | 76,462 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $308,666 | 58,682 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $478,049 | 91,231 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $170,554 | 31,468 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $109,564 | 29,453 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||